IL17A Depletion Affects the Metabolism of Macrophages Treated with Gemcitabine
Background: Interleukin (IL)17A is a member of the IL17 cytokine family, which is released by both immune and non-immune cells such as tumor and stromal cells into the tumor microenvironment. IL17 receptors are also widely expressed in different type of cells. Among all the members, IL17A is the mos...
Saved in:
Main Authors: | Cecilia Roux (Author), Gianluca Mucciolo (Author), Joanna Kopecka (Author), Francesco Novelli (Author), Chiara Riganti (Author), Paola Cappello (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Lurbinectedin induces depletion of tumor-associated macrophages, an essential component of its in vivo synergism with gemcitabine, in pancreatic adenocarcinoma mouse models
by: María Virtudes Céspedes, et al.
Published: (2016) -
Editorial: Novel therapeutic approaches to target drug resistant tumors
by: Chiara Riganti, et al.
Published: (2023) -
M1 Macrophage-Derived Exosomes Loaded with Gemcitabine and Deferasirox against Chemoresistant Pancreatic Cancer
by: Yongmei Zhao, et al.
Published: (2021) -
Depletion of regulatory T cells leads to an exacerbation of delayed-type hypersensitivity arthritis in C57BL/6 mice that can be counteracted by IL-17 blockade
by: Sara Marie Atkinson, et al.
Published: (2016) -
Endothelial-specific depletion of TGF-β signaling affects lymphatic function
by: Kunpei Fukasawa, et al.
Published: (2021)